Tuesday 17 January 2017 12:41 pm Share whatsapp whatsapp As for the full-year, the bank reported net revenues of $34.6bn, down two per cent from $35.2bn the year before, and net income of $6bn, down two per cent from $6.1bn the year before. Earnings per share for the full-year were $2.92.A poll of analysts by Yahoo Finance had predicted full-year revenue of $34.1bn and earnings per share of $2.76. For the fourth quarter, the banks was expected to pull in $8.5bn in revenue and $0.65 in earnings per share. Shares are up 1.4 per cent at $44.28 in pre-market trading. Why it’s importantIn particular, Morgan Stanley’s revenues in its fixed income sales and trading soared to $1.5bn in its fourth quarter of the year, almost triple the $550m it reported in the same business stream a year ago, as the market for bonds became a busy one around the US election.Banks have been having a tough time as of late. Revenues have been squeezed by central banks favouring rock bottom interest rates over recent years, while costs have been pushed up by increasing amounts of red tape. Hayley Kirton Morgan Stanley has given Wall Street something to smile about, reporting better than expected results, with profits and revenues booming in its fourth quarter thanks to a boost in bond trading.The figuresThe US banking giant announced net revenue of $9bn (£7.4bn) for the fourth quarter of 2016, up 17 per cent from $7.7bn for the same period a year ago, and net income applicable to the bank of $1.7bn, up 83 per cent from $908m. The bank also reported earnings per share of $0.81. More From Our Partners Florida woman allegedly crashes children’s birthday party, rapes teennypost.comBrave 7-Year-old Boy Swims an Hour to Rescue His Dad and Little Sistergoodnewsnetwork.orgFeds seized 18 devices from Rudy Giuliani and his employees in April raidnypost.comNative American Tribe Gets Back Sacred Island Taken 160 Years Agogoodnewsnetwork.orgBiden received funds from top Russia lobbyist before Nord Stream 2 giveawaynypost.comAstounding Fossil Discovery in California After Man Looks Closelygoodnewsnetwork.orgRussell Wilson, AOC among many voicing support for Naomi Osakacbsnews.comPolice Capture Elusive Tiger Poacher After 20 Years of Pursuing the Huntergoodnewsnetwork.orgA ProPublica investigation has caused outrage in the U.S. this weekvaluewalk.com 2016 not so bad for Morgan Stanley: Bank’s fourth quarter results sail past expectations However, Morgan Stanley has joined JP Morgan, which reported its fourth-quarter results on Friday, in showing the banks are back in action with better figures than analysts had them pegged for. Lots of eyes will likely now be on Goldman Sachs when it reports tomorrow. What Morgan Stanley said”Our quarterly results reflect consistent strong performance, while our annual results show meaningful earnings growth over 2015,” said James Gorman, chairman and chief executive. “We reported solid results in sales & trading and advisory, and record revenues in wealth management, while managing expenses prudently.”We are optimistic about opportunities in 2017 and beyond and remain focused on serving our clients and achieving our strategic objectives.”In shortIt’s starting to look like 2016 was a good year for the US banking giants, as fixed income trading boomed thanks to a certain event last November.
The Eurozone’s economy lost momentum again in March as Germany and France’s manufacturing sectors struggled to overcome global headwinds, according to a closely-followed indicator.Read more: Wages up across Europe despite gloomy economic climate Euro drops as Eurozone manufacturing activity hits six-year low Manufacturers across the economic area suffered their steepest downturn in seven years this month, the IHS Markit Eurozone composite purchasing managers’ index (PMI) found today.That meant the Eurozone’s PMI expanded only “modestly” to 51.3, the index warned, down from February’s 51.9, and the third lowest reading since November 2014.Anything above a measure of 50 indicates growth.Manufacturing fell to 47.7 from 49.4 in February, its worst drop since April 2013, as the data revealed that output is now shrinking.Both Germany and France’s manufacturing sectors entered decline, sending the euro 0.5 per cent down to $1.132. whatsapp Phil Smith, principal economist at IHS Markit, warned Germany’s manufacturing downturn “has become more entrenched”, blaming Brexit uncertainty, the US-China trade war and a slowdown in car sales.Overall, Germany skated close to hitting recession with a composite output reading of 51.5, while France began to contract, with a reading of 48.7.IHS Markit economist Eliot Kerr added: “At the end of the first quarter, the French private sector was unable to continue the recovery seen in February, as both the manufacturing and service sectors registered contractions in business activity.”The economic research firm warned that of all indicators, the biggest concern was the state of the Eurozone’s manufacturing industry.“Most worrying is the plight of the manufacturing sector, which is now in its deepest downturn since 2013 as trade flows contracted at the sharpest rate since the debt crisis-ridden days of 2012,” Chris Williamson, chief business economist at IHS Markit, said. Tags: Brexit Eurozone Manufacturing sector whatsapp “The service sector is showing more resilience, notably in Germany, but remains in one of its worst growth patches since 2016.”He warned any further loss of momentum in the second quarter would throw doubt on the economy’s chances of growing by more than one per cent this year.Read more: Euro falls as Eurozone growth forecasts slashedBut the outlook does not look good, he said, adding: “Forward-looking indicators such as business optimism and backlogs of work suggest that growth could be even weaker in the second quarter.” by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May Likebonvoyaged.comThese Celebs Are Complete Jerks In Real Life.bonvoyaged.comBleacherBreaker4 Sisters Take The Same Picture For 40 Years. Don’t Cry When You See The Last One!BleacherBreakerDefinitionMost Embarrassing Mistakes Ever Made In HistoryDefinitionFilm OracleThey Drained Niagara Falls – Their Gruesome Find Will Keep You Up All NightFilm OraclePost FunA Coast Guard Spotted Movement On A Remote Island, Then Looked CloserPost FunZen HeraldEllen Got A Little Too Personal With Blake Shelton, So He Said ThisZen HeraldMisterStoryWoman files for divorce after seeing this photoMisterStoryHealthyGem20 Hair Shapes That Make A Man Over 60 Look 40HealthyGemPets DetectiveAfter Céline Dion’s Major Weight Loss, She Confirms What We Suspected All AlongPets Detective Friday 22 March 2019 10:28 am Share Joe Curtis
UncategorizedReview: Alvin Ailey American Dance Theater Continues at the Dorothy Chandler PavilionBy Leilah Bernstein – April 15, 2011549ShareEmailFacebookTwitterPinterestReddItThe mark of an exceptional dance company hinges not only on fine technique and creative choreography, but also on stylistic range. Each of these factors—and most notably the last—was on display Wednesday night at the Music Center, as Alvin Ailey continued its ten-performance run through Sunday.The first two-thirds of the program differed from Friday night’s (see our previous review here), with two outstanding pieces that showed off the company’s artistic scope. Love Stories, choreographed by Judith Jamison (the outgoing artistic director) with Robert Battle (who will be taking her place) and Rennie Harris, included the familiar, catchy tunes of Stevie Wonder, Clarence Paul, and Henry Cosby. Jamar Roberts performed an opening solo, full of strength, athleticism, and control. From there a colorful cacophony of dancers, ten in all, took to the stage for a series of spunky, seemingly free-form moves reminiscent of street dance. Polished and poised even as the music quickened and the acrobatics became more intricate, the dancers expressed the pure fun and boundless joy of dancing. If you were in the audience, you wanted to get up and follow along.The second segment, Forgotten Time, was choreographed by Jamison in 1989, the year Alvin Ailey appointed her to her post. Music by Le Mystere des Voix Bulgares accompanied the piece, which was a somber celebration of the human form—sometimes, in fact, performed in silence. Slow, thoughtful, and deliberate, it was the antithesis in pacing and mood of Love Stories. The dancers, wearing nude-colored leotards with piping, huddled together to create statuesque shapes, or they broke off into small groups or performed duets that were raw, bodies intertwined. “Oh my God, how can he do that?” whispered someone in the audience as one dancer performed a feat of flexibility. The lighting, by Timothy Hunter, was particularly beautiful (shadows, outlines) in setting the scenes.The crowd-favorite Revelations ended the evening, and in the short film shown beforehand, Jamison remarked on the inspiration behind Ailey’s choreography 50 years ago: “If you were a dancer and an African American, my God you had a lot to say—because your story wasn’t being told.” She explained that the moves Ailey fans love today (arms outstretched reaching to the sky, hips swaying like a rippling river) reflect the transformative nature of the African American experience: “We’re joyous in that we see hope from despair.” And in that regard—in showing such breadth—the company continues to resonate with its audience. We hope it returns soon.Jamar Roberts and Antonio Douthit in Forgotten Time, choreographed by Judith Jamison. Photograph by Paul KolnikClifton Brown and Linda Celeste Sims in Forgotten Time, choreographed by Judith Jamison. Photograph by Paul KolnikClifton Brown in Love Stories, choreographed by Judith Jamison with Robert Battle and Rennie Harris. Photograph by Paul Kolnik TAGS2011April 2011L.A. CulturePrevious articleGambling Ships off Santa MonicaNext articleSinging on Sunday with Della ReeseLeilah Bernstein RELATED ARTICLESMORE FROM AUTHORFollow in Pee-wee Herman’s Footsteps Across L.A.What Defines a Successful Immigrant?The Undocumented Immigrants Who Are Redefining ‘American’
By Mike Wackett 16/11/2015 Irish Continental Group has changed tack on its long-held policy of only chartering-in containerships, purchasing four of the five vessels its container line subsidiary, Eucon, operates on its feeder and door-to-door services between Dublin, Cork, Belfast and Rotterdam and Antwerp.Dublin-headquartered ICG took advantage of weak market conditions to snap up the 980 teu Elbfeeder, Elbtrader and Elbcarrier, paying just $21.8m for the seven-year-olds, from their German KG owner, and $5m for the 2005-built 800 teu Jork Ranger, according to www.vesselsvalue.com.ICG said the vessels would initially continue to be used on Eucon routes, but may be made available on a charter basis.”Containership charter rates remain depressed, while liner and feeder operators can easily fix and off-hire ships depending on demand requirements, so it is interesting that ICG has become a containership owner – although it has experience as a ferry and ro-ro vessel owner and operator.ICG enjoyed a good third quarter, growing revenue by 10.4%, compared with the same period of last year, to €105.5m, growing EBITDA from €28.4m to €38.6m and net operating profit from €24m to €34.2m.“Summer trading has been strong with volume and revenue growth across the group’s two operating segments, ferries and container & terminal,” said the operator.In the nine-month period, group turnover was ahead 9.9% to €248.6m, while net profit stood at €50.6m, versus €29.2m in the same period of 2014.Eucon operates a vessel-sharing agreement with Peel Ports-owned BG Freight Line between the Irish Sea and North Europe, and carries around 55% of its business on a door-to-door basis, with the remainder as feeder traffic. This means it is less exposed to reduced feeder volumes from its carrier clients than some of its peers.Despite freight rates continuing under severe pressure, ICG has mitigated some of the impact by not being required to burn the more expensive low-sulphur fuel while its ships are steaming in the Irish Sea, and has therefore reaped extra benefit from the continued decline in bunker prices.In a trading update covering the period from July 1 to November 7, ICG said Eucon carried 3% more volume year on year, at 247,500 teu.Another significant development in 2015 was winning the Victoria Terminal 3 (VT3) container terminal operating services concession in Belfast. This has enabled ICG to consolidate its container volumes from its original Belfast Container Terminal (BCT) facility to VT3, and it now becomes the sole box terminal in the Northern Irish port.However, with a current estimated annual throughput of around 125,000 units, its 150,000 unit capacity at VT3 could soon be exceeded.ICG also operates its own container terminal at Dublin (DFT), and the number of units lifted at its Dublin and Belfast container terminals increased by 29% in the period to 207,900 lifts, mainly due to the VT3 development, with the underlying number up by 5%.
By David Badger 17/08/2016 Meanwhile, Thomas Krüger has been appointed managing director of Air & Sea Logistics EMEAAs managing director of Air & Sea Logistics EMEA, a role he assumed on July 1, Thomas Krüger (52) reports directly to Thomas Reuter. Krüger (pictured right) has held a variety of management positions at Dachser Air & Sea Logistics. From 2004 to 2006, he was sales manager for Germany, after which he headed up global sales management until 2012. Most recently, he was responsible for the Northern Central Europe (NCE) region. He succeeded Rüdiger Klug, who joined Dachser in 2009 and retired on June 30, 2016. Experienced logistics manager Jochen Müller (52) will be joining the Dachser team. On January 1, 2018, he will take over from Thomas Reuter as Chief Operations Officer (COO) of the Air & Sea Logistics business field. The transition period, during which Müller will work on developing projects, will start on October 1 of this year. Thomas Reuter will remain on the board in his role as head of Air & Sea Logistics through the transition period until he retires on December 31, 2017.Jochen Müller (pictured left) was born in 1964 in Worms, Germany. In 2011, he joined the board of Schenker Deutschland AG, where he was in charge of air freight and sales (Air/Sea) for Central Europe, as well as logistics for worldwide relocations, trade shows, and sporting events. Prior to that, Müller served as CEO of Schenker’s British country organisation, where he was responsible for land, air, and sea freight as well as the trade show business.“Jochen Müller is a top manager and logistics expert with extensive experience in air and sea freight, but he is familiar with the requirements and processes of overland transport as well,” says Bernhard Simon, CEO of Dachser. “As COO of Air & Sea Logistics and future member of the Executive Board, he will build on what Thomas Reuter has accomplished. This will include further expanding our intercontinental air and sea freight network and creating a closer link with our comprehensive European overland transport network. All of this will enable us to intelligently dovetail customer supply chains.”Given Müller’s past experience and the strategically planned preparation period, the transition should go smoothly when he takes over from Thomas Reuter as Air & Sea Logistics COO. Reuter has worked at Dachser since 1978 and has been a member of the Executive Board since early 2006. He played a major role in the internationalization of the logistics supplier by building up a global network of air and sea freight locations. The Air & Sea Logistics business field currently has 196 locations and close to 4,000 employees, and posted roughly EUR 1.6 billion in sales in 2015.
Alex Hogan/STAT The field, in short, seems ripe for revolution. But entrepreneurs entering the market also face risks. Drug-delivery systems are quicker to bring to market than traditional pharmaceuticals — but don’t make as much money. Valuations stay modest. Very few drug-delivery companies, among them BIND Therapeutics and Cerulean Pharma, have gone public.And new drug-delivery technologies could pose risks to patients. Nanomaterials have been heralded for their potential in delivering drugs to spinal cord injuries and tumors, but a review published this year called for further investigation of the material’s potential toxic effects. And while 3-D printing has sparked excitement about the potential for patients to get their pills in the shape that works best for them, a study published last year found that changes in the size and shape of pills can lead to patients skipping doses. Related: Precision medicine, linked to DNA, still too often misses Device uses ultrasound to deliver drugs In the LabNot your grandma’s pills: 7 intriguing new ways to deliver drugs Related: Implanted devicesThe problem: Pills can be forgotten, misplaced, stolen, sold on the black market, or gobbled up by kids.Potential solution: A device implanted under the skin, tested in patients with opioid addiction, dispenses medication for six months.Who’s working on it: Titan Pharmaceuticals, a San Francisco specialty pharma companyAlex Hogan/STATRemote-controlled deliveryThe problem: Drugs for neurological disorders often have terrible side effects.Potential solution: A remote-controlled device, tested in mice, would be implanted in the brain to precisely deliver drugs to specific regions of the brain that need it, bypassing regions that don’t.Who’s working on it: Researchers at Washington University in St. Louis; University of Colorado, Boulder; and University of Illinois, Urbana-ChampaignAlex Hogan/STATMicroneedle patchThe problem: Medical professionals aren’t always around.Potential solution: An experimental microneedle patch, tested in patients, would deliver a flu vaccine without the need for needles or trained technicians.Who’s working on it: Researchers at Osaka University in JapanAlex Hogan/STATCell squeezingThe problem: It can be hard to get drugs into a cell.Potential solution: An experimental device, tested in mice, squeezes cells like a sponge, opening up tiny pores in the cell’s exterior membrane through which foreign molecules can flow.Who’s working on it: SQZ Biotech, a Boston startupAlex Hogan/STATTumor implantThe problem: Testing one oncology drug at a time on a tumor takes too long and can have toxic effects.Potential solution: A tiny device, being tested in breast cancer patients, could be implanted into a tumor to dispense small doses of up to 30 different drugs at a time.Who’s working on it: Researchers at MITAlex Hogan/STATMany of the new technologies are still being fine-tuned in academic labs or tested in animals. But money is flowing in, particularly for concepts that are closer to market. Last year, investment in drug-delivery companies exceeded $250 million, according to the financial information firm Dow Jones. And the worldwide market for drug-delivery technologies is expected to exceed $150 billion this year, according to the London research firm Visiongain. Big Pharma is taking notice, too: Roche this week partnered with startup SQZ Biotech to find new uses for technology the startup developed to push drugs into cells. Teva Pharmaceuticals earlier this year inked its own partnership with drug delivery company Microchips Biotech. And Allergan last year acquired the drug-delivery technology of another startup, TARIS Biomedical.The reason for all this interest? There’s a lot that isn’t working with today’s drug-delivery systems.Injections can be painful and inconvenient. Steroids and chemotherapy can have side effects. Daily pills are easily abused or difficult to remember to take, particularly for patients with cognitive conditions like Alzheimer’s disease or schizophrenia.And then there’s the issue of targeting. Sometimes drugs can’t penetrate the thick membranes of the organs they’re trying to reach; other times they act on the wrong places, needlessly impairing cognition or causing liver or kidney damage. An expanding ringThe problem: Stomach drugs that are supposed to be long-acting get flushed out too quickly.Potential solution: A swallowable pill, tested in pigs, unfolds into a ring when it reaches the stomach, allowing it to dispense medication for longer than a week.Who’s working on it: Lyndra, a Cambridge biotech startupAlex Hogan/STAT3-D printingThe problem: Some patients need drugs dispensed in different amounts, at different speeds, or to different regions.Potential solution: A 3-D printing technology, tested in vitro, could customize dosages with unusually shaped pills or designs that pack multiple drugs into one pill.Who’s working on it: Researchers at University College London’s School of Pharmacyadvertisement By Rebecca Robbins Dec. 8, 2015 Reprints The quest to develop the next miracle pill commands the biggest bucks and the most attention in biotech. But out of the spotlight, there’s growing interest in finding better ways to deliver existing drugs into the body.Academic researchers and startups are working on new technologies that sound fantastical: Microbubbles. Pills shaped like donuts and pyramids. Devices that could “turn on” drugs, like a TV remote, by flashing beams of light. Tiny chips that might be able to stay in your body for as long as 16 years.We’ve rounded up some of the most intriguing ideas in the field of drug delivery. Here’s just a sampling of those efforts:advertisement Tags biotechdrug deliverydrugs
Electric Picnic organisers release statement following confirmation of new festival date News Revenue have contacted around 3,000 taxpayers who they say have been the victims of ‘fraudulent texts’.There is an ongoing circulation of a number of ‘scam’ text messages, purporting to come from Revenue, that contain a link to a fraudulent website which seek personal information from taxpayers.These texts do not come from Revenue, they are in fact from fraudsters.As a result of information provided by them as part of a recent scam, personal details held in the user profile of their Revenue myAccount may have been accessed by the fraudsters.Revenue’s Chief Information Officer, John Barron, said: “Revenue constantly monitors for suspect online activity on all its services and takes action as soon as such activity comes to light.“For example, where potential phishing websites are detected, we immediately seek to have them taken offline by reputable hosting services.“Following an investigation by Revenue’s IT Department into this latest scam, we are contacting approximately 3,000 taxpayers to make them aware of our concerns that their personal details may have been accessed, the possible serious implications for them and to set out some practical things they can do to minimise the extent of any fraud perpetrated against them.“It is important to note that the security of Revenue’s systems has not been compromised in any way. TAGSRevenue RELATED ARTICLESMORE FROM AUTHOR Pinterest WhatsApp “However, the nature of this particular type of scam has led to some taxpayers unwittingly compromising the security of their personal myAccount profile details by providing information such as their PPSN, Date of Birth and myAccount password to fraudsters.“This occurred after the taxpayer clicked on a link, in a text sent by fraudsters, which purported to be the Revenue ‘myAccount’ log-in screen.“If the details provided after clicking the link are valid, the fraudsters then use these details provided by the taxpayer to access the taxpayer’s myAccount user profile screen.“At this stage they may be able to obtain further information including potentially bank details where the taxpayer has recorded these with Revenue.“In order to mitigate any further threat to the accounts that could have been potentially compromised, we are now contacting each of the taxpayers by letter informing them of possible fraudulent activity that may have affected their account.The letter notifies the taxpayer that Revenue has temporarily deactivated their myAccount access and advises them of important next steps they should follow.”SEE ALSO – Minister Flanagan steps in to block ‘family visit’ for Laois man who murdered Carlow mother Twitter Electric Picnic WhatsApp Pinterest Facebook Facebook Bizarre situation as Ben Brennan breaks up Fianna Fáil-Fine Gael arrangement to take Graiguecullen-Portarlington vice-chair role Twitter Revenue contacts taxpayers who have been the target of fraudulent texts By Alan Hartnett – 29th May 2020 Electric Picnic Laois Councillor ‘amazed’ at Electric Picnic decision to apply for later date for 2021 festival Home News Revenue contacts taxpayers who have been the target of fraudulent texts News Previous articleDeaths in Laois – Friday, May 29, 2020Next articleWATCH: Laois students record stunning rendition of ‘Wicked’ classic to celebrate finishing school Alan HartnettStradbally native Alan Hartnett is a graduate of Knockbeg College who has worked in the local and national media since 2008. Alan has a BA in Economics, Politics and Law and an MA in Journalism from DCU. His happiest moment was when Jody Dillon scored THAT goal in the Laois senior football final in 2016.
Community Pharmacy in Health Care Homes Trial Program coming to an end The Australian Government has confirmed that the Community Pharmacy in Health Care Homes Trial Program will end on 30 June 2021 in line with the ending of the broader Health Care Homes Trial.The Community Pharmacy in Health Care Homes Trial Program is funded by the Australian Government under the Sixth Community Pharmacy Agreement (6CPA) as part of a package of measures to support new and expanded 6CPA Community Pharmacy Programs including incorporation of medication management programs within Health Care Homes.Health Care Homes are general practices or Aboriginal Community Controlled Health Services that provide better coordinated and more flexible care for Australians with chronic and complex health conditions. The Health Care Homes model was designed to help Australians better manage their conditions by giving them access to coordinated, integrated care, tailored to their needs.Through the community pharmacy trial patients have benefited from patient-centred, coordinated medication management services delivered by their community pharmacy of choice in conjunction with their Health Care Home.The Guild thanks all community pharmacies that have participated in this significant trial with the goal of improving the health outcomes of people with complex and chronic conditions in Australia.After the trial ends on 30 June 2021, the trial outcomes will be evaluated and a final report will be published on the Australian Government Department of Health’s website. Further information on the community pharmacy trial is available on the trial website. /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:Aboriginal, agreement, Australia, Australian, Australian Government, chronic, community, Department of Health, general practice, Government, health, health services, outcomes, pharmacy, Pharmacy Guild of Australia, trial, website